Usability and Clinical Decision Support Part 2: Drug-Drug Interaction Checkers
By David Schlossman, MD, PhD, FACP, MMI, CPHIMS, Medical Oncologist/Board, Certified Clinical Informaticist, Missouri Cancer Associates/Boone Hospital Center
One commonly studied example of alert fatigue is drug-drug interaction (DDI) alerts, since DDI alerts are a requirement for both Stage 1 and Stage 2 Meaningful Use compliance. The requirement was established with the expectation that such alerts would significantly reduce the incidence of adverse drug events (ADEs). Unfortunately, what I’ve seen is the majority of DDI checkers supplied in large commercial EHRs are too nonspecific and clinically unaware.
View original post 619 more words